目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Type
Market segments
Comparison by Type
Hypothyroidism - Market size and forecast 2020-2025
Hyperthyroidism - Market size and forecast 2020-2025
Market opportunity by Type

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Abbott Laboratories
AbbVie Inc.
Alvogen ehf
Amgen Inc.
GlaxoSmithKline Plc
Lannett Co. Inc.
Merck KGaA
Pfizer Inc.
RLC Labs Inc.
Viatris Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
Exhibits1: Key Finding 1
Exhibits2: Key Finding 2
Exhibits3: Key Finding 3
Exhibits4: Key Finding 5
Exhibits5: Key Finding 6
Exhibits6: Key Finding 7
Exhibits7: Key Finding 8
Exhibits8: Parent market
Exhibits9: Market characteristics
Exhibits10: Offerings of vendors included in the market definition
Exhibits11: Market segments
Exhibits12: Global - Market size and forecast 2020 - 2025 ($ million)
Exhibits13: Global market: Year-over-year growth 2020 - 2025 (%)
Exhibits14: Five forces analysis 2020 & 2025
Exhibits15: Bargaining power of buyers
Exhibits16: Bargaining power of suppliers
Exhibits17: Threat of new entrants
Exhibits18: Threat of substitutes
Exhibits19: Threat of rivalry
Exhibits20: Market condition - Five forces 2020
Exhibits21: Type - Market share 2020-2025 (%)
Exhibits22: Comparison by Type
Exhibits23: Hypothyroidism - Market size and forecast 2020-2025 ($ million)
Exhibits24: Hypothyroidism - Year-over-year growth 2020-2025 (%)
Exhibits25: Hyperthyroidism - Market size and forecast 2020-2025 ($ million)
Exhibits26: Hyperthyroidism - Year-over-year growth 2020-2025 (%)
Exhibits27: Market opportunity by Type
Exhibits28: Customer landscape
Exhibits29: Market share By Geographical Landscape 2020-2025 (%)
Exhibits30: Geographic comparison
Exhibits31: North America - Market size and forecast 2020-2025 ($ million)
Exhibits32: North America - Year-over-year growth 2020-2025 (%)
Exhibits33: Europe - Market size and forecast 2020-2025 ($ million)
Exhibits34: Europe - Year-over-year growth 2020-2025 (%)
Exhibits35: Asia - Market size and forecast 2020-2025 ($ million)
Exhibits36: Asia - Year-over-year growth 2020-2025 (%)
Exhibits37: ROW - Market size and forecast 2020-2025 ($ million)
Exhibits38: ROW - Year-over-year growth 2020-2025 (%)
Exhibits39: Key leading countries
Exhibits40: Market opportunity By Geographical Landscape ($ million)
Exhibits41: Impact of drivers and challenges
Exhibits42: Vendor landscape
Exhibits43: Landscape disruption
Exhibits44: Industry risks
Exhibits45: Vendors covered
Exhibits46: Market positioning of vendors
Exhibits47: Abbott Laboratories - Overview
Exhibits48: Abbott Laboratories - Business segments
Exhibits49: Abbott Laboratories - Key offerings
Exhibits50: Abbott Laboratories - Key customers
Exhibits51: Abbott Laboratories - Segment focus
Exhibits52: AbbVie Inc. - Overview
Exhibits53: AbbVie Inc. - Product and service
Exhibits54: AbbVie Inc. - Key offerings
Exhibits55: AbbVie Inc. - Key customers
Exhibits56: AbbVie Inc. - Segment focus
Exhibits57: Alvogen ehf - Overview
Exhibits58: Alvogen ehf - Product and service
Exhibits59: Alvogen ehf - Key offerings
Exhibits60: Alvogen ehf - Key customers
Exhibits61: Alvogen ehf - Segment focus
Exhibits62: Amgen Inc. - Overview
Exhibits63: Amgen Inc. - Business segments
Exhibits64: Amgen Inc. - Key offerings
Exhibits65: Amgen Inc. - Key customers
Exhibits66: Amgen Inc. - Segment focus
Exhibits67: GlaxoSmithKline Plc - Overview
Exhibits68: GlaxoSmithKline Plc - Business segments
Exhibits69: GlaxoSmithKline Plc - Key offerings
Exhibits70: GlaxoSmithKline Plc - Key customers
Exhibits71: GlaxoSmithKline Plc - Segment focus
Exhibits72: Lannett Co. Inc. - Overview
Exhibits73: Lannett Co. Inc. - Business segments
Exhibits74: Lannett Co. Inc. - Key offerings
Exhibits75: Lannett Co. Inc. - Key customers
Exhibits76: Lannett Co. Inc. - Segment focus
Exhibits77: Merck KGaA - Overview
Exhibits78: Merck KGaA - Business segments
Exhibits79: Merck KGaA - Key offerings
Exhibits80: Merck KGaA - Key customers
Exhibits81: Merck KGaA - Segment focus
Exhibits82: Pfizer Inc. - Overview
Exhibits83: Pfizer Inc. - Business segments
Exhibits84: Pfizer Inc. - Key offerings
Exhibits85: Pfizer Inc. - Key customers
Exhibits86: Pfizer Inc. - Segment focus
Exhibits87: RLC Labs Inc. - Overview
Exhibits88: RLC Labs Inc. - Product and service
Exhibits89: RLC Labs Inc. - Key offerings
Exhibits90: RLC Labs Inc. - Key customers
Exhibits91: RLC Labs Inc. - Segment focus
Exhibits92: Viatris Inc. - Overview
Exhibits93: Viatris Inc. - Business segments
Exhibits94: Viatris Inc. - Key offerings
Exhibits95: Viatris Inc. - Key customers
Exhibits96: Viatris Inc. - Segment focus
Exhibits97: Currency conversion rates for US$
Exhibits98: Research Methodology
Exhibits99: Validation techniques employed for market sizing
Exhibits100: Information sources
Exhibits101: List of abbreviations